Porton Pharma Solutions
Trending Articles
Related Content
Ingredients
Global partnership to expand pharma biocatalysis uptake
Codexis, Inc. and Porton Pharma Solutions recently announced a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active pharmaceutical ingredients (API) development and manufacturing business. Dr Kevin Robinson caught up with Porton’s Oliver Ju and Codexis’ John Nicols to find our more
Manufacturing
Porton Pharma Solutions and BioDuro announce strategic alliance
Porton Pharma Solutions, a leading provider of custom, cross lifecycle active pharmaceutical ingredient (API) development and cGMP manufacturing services to the global drug industry, and BioDuro LLC, a leading global life sciences contract research, development and manufacturing organisation, have announced a strategic alliance and comarketing partnership